211 related articles for article (PubMed ID: 33832504)
1. Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site.
Wiercinska E; Schlipfenbacher V; Bug G; Bader P; Verbeek M; Seifried E; Bonig H
J Transl Med; 2021 Apr; 19(1):145. PubMed ID: 33832504
[TBL] [Abstract][Full Text] [Related]
2. A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.
Laroye C; Thilly N; Gauthier M; Luc A; Latger-Cannard V; Eschwege V; Bensoussan D; Pochon C; Campidelli A; Rubio MT; D'Aveni M; Decot V
Cytotherapy; 2023 Aug; 25(8):877-884. PubMed ID: 37178096
[TBL] [Abstract][Full Text] [Related]
3. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
[TBL] [Abstract][Full Text] [Related]
4. Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.
Keyzner A; Azzi J; Jakubowski R; Sinitsyn Y; Tindle S; Shpontak S; Kwon D; Isola L; Iancu-Rubin C
Transplant Proc; 2023 Oct; 55(8):1799-1809. PubMed ID: 37210273
[TBL] [Abstract][Full Text] [Related]
5. Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic.
Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N
Transplant Cell Ther; 2021 Dec; 27(12):1022.e1-1022.e6. PubMed ID: 34571211
[TBL] [Abstract][Full Text] [Related]
6. Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic.
Purtill D; Antonenas V; Chiappini P; Tong D; O'Flaherty E; Bajel A; Kabani K; Larsen S; Tan S; Hutchins C; Curtis DJ; Kennedy GA; Watson AM; Bai L; Greenwood M; Gottlieb DJ; Hamad N
Blood Adv; 2020 Sep; 4(17):4147-4150. PubMed ID: 32886750
[TBL] [Abstract][Full Text] [Related]
7. Pre infusion, post thaw CD34+ peripheral blood stem cell enumeration as a predictor of haematopoietic engraftment in autologous haematopoietic cell transplantation.
D'Rozario J; Parisotto R; Stapleton J; Gidley A; Owen D
Transfus Apher Sci; 2014 Jun; 50(3):443-50. PubMed ID: 24680293
[TBL] [Abstract][Full Text] [Related]
8. Improved post-thaw recovery of peripheral blood stem/progenitor cells using a novel intracellular-like cryopreservation solution.
Clarke DM; Yadock DJ; Nicoud IB; Mathew AJ; Heimfeld S
Cytotherapy; 2009; 11(4):472-9. PubMed ID: 19499402
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
[TBL] [Abstract][Full Text] [Related]
10. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited Settings.
Gokarn A; Tembhare PR; Syed H; Sanyal I; Kumar R; Parab S; Khanka T; Punatar S; Kedia S; Ghogale SG; Deshpande N; Nikam Y; Girase K; Mirgh S; Jindal N; Bagal B; Chichra A; Nayak L; Bonda A; Rath S; Hiregoudar S; Poojary M; Saha S; Ojha S; Subramanian PG; Khattry N
Transplant Cell Ther; 2023 Dec; 29(12):777.e1-777.e8. PubMed ID: 37678607
[TBL] [Abstract][Full Text] [Related]
12. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
[TBL] [Abstract][Full Text] [Related]
13. Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report.
Bankova AK; Caveney J; Yao B; Ramos TL; Bögeholz J; Heydari K; Diaz N; Jackson ML; Lowsky R; Brown JW; Johnston L; Rezvani AR; Frank MJ; Muffly L; Weng WK; Sidana S; Negrin RS; Miklos DB; Shiraz P; Meyer EH; Shizuru JA; Arai S
Transplant Cell Ther; 2022 Apr; 28(4):215.e1-215.e10. PubMed ID: 35042013
[TBL] [Abstract][Full Text] [Related]
14. Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products.
Berens C; Heine A; Müller J; Held SA; Mayer K; Brossart P; Oldenburg J; Pötzsch B; Wolf D; Rühl H
Cytotherapy; 2016 Oct; 18(10):1325-31. PubMed ID: 27491794
[TBL] [Abstract][Full Text] [Related]
15. Effects of extended transport on cryopreserved allogeneic hematopoietic progenitor cell (HPC) product quality and optimal methods to assess HPC stability.
Reddy OL; Sall MT; Dinh A; Cai Y; Ongkeko M; Arya N; Wilder J; Tran M; Jin P; Stroncek DF; Panch SR
Transfusion; 2023 Apr; 63(4):774-781. PubMed ID: 36975826
[TBL] [Abstract][Full Text] [Related]
16. The impact of cryoprotectant exposure time on post-thaw viability of autologous and allogeneic hematopoietic stem cells and leukocyte subpopulations.
Rimac V; Bojanić I; Dabelić S; Ćepulić BG
Acta Pharm; 2023 Dec; 73(4):655-672. PubMed ID: 38147484
[TBL] [Abstract][Full Text] [Related]
17. The Viability of Hematopoietic Progenitor Cell Grafts after Cryopreservation Does Not Predict Delayed Engraftment in Allogeneic Hematopoietic Stem Cell Transplantation.
Fadeyi E; Mamo YT; Saha AK; Wilson E; Pomper G
Lab Med; 2022 Sep; 53(5):509-513. PubMed ID: 35640044
[TBL] [Abstract][Full Text] [Related]
18. The loss of CD34+ cells in peripheral hematopoietic stem cell products cryopreserved by non-controlled rate freezing and stored at -80 °C after overnight storage.
Donmez A; Yilmaz F; Soyer N; Cagirgan S; Arik B; Tombuloglu M
Transfus Apher Sci; 2014 Oct; 51(2):188-92. PubMed ID: 25217992
[TBL] [Abstract][Full Text] [Related]
19. Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2x10(6) CD34+ cells/kg.
Abrahamsen JF; Wentzel-Larsen T; Bruserud O
Cytotherapy; 2004; 6(4):356-62. PubMed ID: 16146888
[TBL] [Abstract][Full Text] [Related]
20. Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program.
Kanda Y; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Kodera Y
Transplant Cell Ther; 2021 Aug; 27(8):664.e1-664.e6. PubMed ID: 33964514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]